WO2003072049A3 - Induction of hair growth with vascular endothelial growth factor - Google Patents

Induction of hair growth with vascular endothelial growth factor Download PDF

Info

Publication number
WO2003072049A3
WO2003072049A3 PCT/US2003/005564 US0305564W WO03072049A3 WO 2003072049 A3 WO2003072049 A3 WO 2003072049A3 US 0305564 W US0305564 W US 0305564W WO 03072049 A3 WO03072049 A3 WO 03072049A3
Authority
WO
WIPO (PCT)
Prior art keywords
vascular endothelial
hair growth
induction
growth factor
hair
Prior art date
Application number
PCT/US2003/005564
Other languages
French (fr)
Other versions
WO2003072049A2 (en
Inventor
Jacob Waugh
Michael Dake
Original Assignee
Essentia Biosystems Inc
Jacob Waugh
Michael Dake
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essentia Biosystems Inc, Jacob Waugh, Michael Dake filed Critical Essentia Biosystems Inc
Priority to AU2003216389A priority Critical patent/AU2003216389A1/en
Publication of WO2003072049A2 publication Critical patent/WO2003072049A2/en
Publication of WO2003072049A3 publication Critical patent/WO2003072049A3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Abstract

A method for inducing or stimulating new hair growth, increasing hair growth or preventing hair regression in a mammalian subject in need of or desirous of such treatment is provided that comprises administering to the subject a pharmaceutically or cosmeceutically effective amount of a composition comprising vascular endothelial growth factor (VEGF), a VEGF receptor agonist, a prodrug form of the foregoing or a salt form thereof in a non-covalent association complex with a positively-charged backbone having a plurality of attached efficiency groups.
PCT/US2003/005564 2002-02-21 2003-02-21 Induction of hair growth with vascular endothelial growth factor WO2003072049A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003216389A AU2003216389A1 (en) 2002-02-21 2003-02-21 Induction of hair growth with vascular endothelial growth factor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35940002P 2002-02-21 2002-02-21
US60/359,400 2002-02-21

Publications (2)

Publication Number Publication Date
WO2003072049A2 WO2003072049A2 (en) 2003-09-04
WO2003072049A3 true WO2003072049A3 (en) 2004-03-25

Family

ID=27766077

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/005564 WO2003072049A2 (en) 2002-02-21 2003-02-21 Induction of hair growth with vascular endothelial growth factor

Country Status (2)

Country Link
AU (1) AU2003216389A1 (en)
WO (1) WO2003072049A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8974774B2 (en) 2004-03-03 2015-03-10 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9180081B2 (en) 2005-03-03 2015-11-10 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
AU2011253597B2 (en) * 2004-03-03 2014-12-04 Revance Therapeutics, Inc. Multi-component biological transport systems
US8022179B2 (en) 2005-03-03 2011-09-20 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of an oligopeptide
EP1880007A2 (en) 2005-05-05 2008-01-23 Genencor International, Inc. Personal care compositions and methods for their use
US8197865B2 (en) 2005-08-09 2012-06-12 Access Business Group International Llc Methods and compositions for modulating hair growth or regrowth
BR122019000266B1 (en) 2007-07-26 2021-09-14 Revance Therapeutics, Inc PHARMACEUTICAL OR COSMETIC COMPOSITION INCLUDING A CATIONIC PEPTIDE AND KIT FOR ADMINISTRATION
CA2715033C (en) 2008-03-14 2014-11-25 Allergan, Inc. Immuno-based botulinum toxin serotype a activity assays
CN102791284A (en) * 2010-02-24 2012-11-21 艾德宛金国际私人有限公司 Method of treatment or prevention of hair loss or for the enhancement of hair growth
ITRM20110406A1 (en) * 2011-07-28 2013-01-29 Giuliani Spa PLANTARICINE AND BIOMASS INCLUDING PLANTARS FOR USE IN THE COSMETIC AND MEDICAL FIELD.
MX370929B (en) 2012-10-28 2020-01-08 Revance Therapeutics Inc Compositions and methods for safe treatment of rhinitis.
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
WO2002007773A2 (en) * 2000-07-21 2002-01-31 Essentia Biosystems, Inc. Multi-component biological transport systems

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
WO2002007773A2 (en) * 2000-07-21 2002-01-31 Essentia Biosystems, Inc. Multi-component biological transport systems

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YANO K.: "Control of hair growth and follicle size by VEGF-mediated angiogenesis", J. OF CLIN. INV., vol. 107, no. 4, February 2001 (2001-02-01), pages 109 - 417, XP002941006 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8974774B2 (en) 2004-03-03 2015-03-10 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US9180081B2 (en) 2005-03-03 2015-11-10 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US9314416B2 (en) 2005-03-03 2016-04-19 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins

Also Published As

Publication number Publication date
AU2003216389A1 (en) 2003-09-09
WO2003072049A2 (en) 2003-09-04
AU2003216389A8 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
WO2003072049A3 (en) Induction of hair growth with vascular endothelial growth factor
DK1638586T3 (en) Synergistic composition for the treatment of diabetes mellitus
WO2005000215A3 (en) Methods for treating pain
DE60307607D1 (en) USE OF SELECTIVE EP4 RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASES
BR0010524A (en) Treatment of refractory human tumors with epidermal growth factor receptor antagonists
RU2011105821A (en) THERAPEUTIC DOSING OF NEUREGULIN OR ITS SEQUENCE FOR THE TREATMENT OR PREVENTION OF HEART FAILURE
CY1112473T1 (en) METHODS OF TREATMENT FOR CANCER-BASED CELLS
AR069830A1 (en) FACTOR VIII AND FACTOR OF VON WILLEBRAND MODIFIED RECOMBINANTS AND METHODS OF USE OF THE SAME
IS8502A (en) Azate cyclic heterocycles as cannabinoid receptor antagonists
EP2628486A3 (en) Method for treating bone fracture with anti-sclerostin antibodies
DE69613348T2 (en) INHIBITATION OF NEOVASCULATION BY VEGF-SPECIFIC OLIGONUCLEOTIDES
AR019671A1 (en) USE OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF (+) NORCISAPRIDA OR A PHARMACOLOGICALLY ACCEPTABLE SALT OF THE SAME SUBSTANTIALLY FREE OF ITS (-) STEREOISOMERO, FOR THE PREPARATION OF A MEDICINAL PRODUCT
EA200200324A1 (en) METHODS OF APPLICATION OF SELECTIVE INHIBITORS OF REVERSE CAPTURE OF SEROTONIN QUICK START FOR TREATMENT OF SEXUAL DYSFUNCTION
WO2001043732A3 (en) Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
SE9900961D0 (en) Novel compounds
ATE496048T1 (en) PHENYLCARBOXAMIDE COMPOUNDS FOR PAIN TREATMENT
WO2000004863A3 (en) Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
DE60016181D1 (en) C-16 UNSATURATED FP-SELECTIVE PROSTAGLANDIN ANALOG
ES2185153T3 (en) USE OF MEFLOQUINA (+) FOR THE TREATMENT OF MALARIA.
WO2009108252A3 (en) Method for stimulating immune response against moraxella catarrhalis
RU2013121802A (en) PREVENTIVE OR THERAPEUTIC AGENT FOR TREATING FIBROSIS
NO20026286D0 (en) New peptides
WO2003099201A3 (en) Compositions and methods of use for a fibroblast growth factor
BRPI0514363A (en) cosmetic and personal care composition, method of treating hair, and use of a dendritically macromolecule constructed from anhydride units
WO2004058803A3 (en) Peptides that bind of the vegfr-2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP